LB Pharmaceuticals Participates in Four Investor Conferences

LB Pharmaceuticals joins Craig-Hallum Biotech Catalyst Conference virtually Oct. 22, 2026, for one-on-one investor meetings; fireside chat at 10 a.m. ET. At Guggenheim Securities’ 3rd Annual Healthcare Innovation Conference in Boston Nov. 9, 2026: one-on-one investor meetings; fireside chat at 1 p.m. ET. Executives will attend one-on-one investor meetings at Wolfe Research Healthcare Conference in New York Nov. 10, 2026. Stifel Healthcare Conference participation in New York Nov. 12, 2026, includes one-on-one investor meetings; fireside chat at 9:20 a.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via (Ref. ID: 202610151605PRIMZONEFULLFEED9846629) on October 15, 2026, and is solely responsible for the information contained therein. (C)